BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32517724)

  • 41. Infection and inflammation leading to clozapine toxicity and intensive care: a case series.
    Leung JG; Nelson S; Takala CR; Gören JL
    Ann Pharmacother; 2014 Jun; 48(6):801-5. PubMed ID: 24619948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
    Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Olanzapine- and clozapine-induced stuttering. A case series.
    Bär KJ; Häger F; Sauer H
    Pharmacopsychiatry; 2004 May; 37(3):131-4. PubMed ID: 15179972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine in the treatment of neuroleptic-induced blepharospasm: a report of 4 cases.
    Levin H; Reddy R
    J Clin Psychiatry; 2000 Feb; 61(2):140-3. PubMed ID: 10732662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study.
    Ziegenbein M; Kropp S; Kuenzel HE
    Clin Neuropharmacol; 2005; 28(5):220-4. PubMed ID: 16239761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clozapine and Olanzapine Associated Atrial Fibrillation: A Case Report].
    Çam B; Gülseren L; Mete L; Gülseren Ş
    Turk Psikiyatri Derg; 2015; 26(3):221-6. PubMed ID: 26364178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autonomic signs and dosing during the initial stages of clozapine therapy.
    Oyewumi LK; Cernovsky ZZ; Freeman DJ
    Med Sci Monit; 2004 Feb; 10(2):PI19-23. PubMed ID: 14737054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B; Petillion A; Martelli C; Benyamina A
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract]   [Full Text] [Related]  

  • 51. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clozapine-induced pericarditis.
    Markovic J; Momcilov-Popin T; Mitrovic D; Ivanovic-Kovacevic S; Sekuli S; Stojsic-Milosavljevic A
    Afr J Psychiatry (Johannesbg); 2011 Jul; 14(3):236-8. PubMed ID: 21863209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Masked clozapine-induced cardiomyopathy.
    Pastor CA; Mehta M
    J Am Board Fam Med; 2008; 21(1):70-4. PubMed ID: 18178706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine induced polyserositis.
    Catalano G; Catalano MC; Frankel Wetter RL
    Clin Neuropharmacol; 1997 Aug; 20(4):352-6. PubMed ID: 9260733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentially fatal outcomes associated with clozapine.
    Li KJ; Gurrera RJ; Delisi LE
    Schizophr Res; 2018 Sep; 199():386-389. PubMed ID: 29503232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clozapine-induced fevers and 1-year clozapine discontinuation rate.
    Tham JC; Dickson RA
    J Clin Psychiatry; 2002 Oct; 63(10):880-4. PubMed ID: 12416597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clozapine-induced tardive dyskinesia: a case report.
    Ertugrul A; Demir B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clozapine-induced myocarditis during co-administration of valproate: A case report.
    Jahołkowski P; Niewiadomska J; Wciórka J; Kowalski M; Świtaj P
    Psychiatr Pol; 2019 Oct; 53(5):997-1002. PubMed ID: 31955181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.